Labarai
Kalubalen da ke tattare da Magance Cutar Fungal Mai Cike da Ciwo a Marasa Lafiyar Jini: Bayani daga ASH 2024
A taron shekara-shekara na ASH na shekarar 2024, Farfesa Sun Yuqian ya raba wani gagarumin bincike kan cututtukan fungal masu saurin yaduwa (bIFD) ga marasa lafiya da ke fama da cututtukan jini, yana mai nuna ƙalubalen bincike da magani, da kuma fahimta mai amfani bisa ga binciken da aka yi kwanan nan.
Ci gaba a Tsarin Rarraba Hadarin T-ALL: Rarraba da aka Yi bisa NGS Ya Gano Ƙungiyoyi Masu Haɗari Masu Yawa
Wani sabon bincike da aka buga a cikin Jini yana inganta rarrabuwar haɗarin cutar sankarar lymphoblastic mai saurin kamuwa da cutar T-cell (T-ALL) ta amfani da tsarin tsarawa na gaba (NGS), yana haɓaka hasashen hasashen yanayi da kuma gano ƙananan ƙungiyoyi masu haɗari waɗanda za su iya amfana daga magungunan da aka yi niyya.
Gudanar da Matsalolin Da Ke Daɗewa na Maganin CAR-T: Fahimta daga Ciwon Daji na Yanayi
Wani bincike da aka buga kwanan nan a cikin Ciwon daji na Yanayi yana nuna matsalolin da ke tattare da maganin ƙwayoyin CAR-T na dogon lokaci, yana mai da hankali kan haɗarin kamuwa da cuta da kuma cututtukan da ke haifar da cutar kansa ta biyu, kuma yana ba da dabarun inganta sakamakon marasa lafiya.
Nasarar Ilimi | Ƙungiyar Likitoci ta Lu Daopei ta Buga Wani Babban Bincike na Asibiti a cikin Mujallar Haematology ta Burtaniya
Ƙungiyar Likitoci ta Lu Daopei, ƙarƙashin jagorancin Dr. Cao Xingyu da Farfesa Lu Peihua, sun buga wani muhimmin takarda na bincike a fannin lafiya a cikin Mujallar Nazarin Haematology ta Burtaniya (Impact Factor 5.1). Binciken ya binciki aminci da ingancin dashen ƙwayoyin halitta na allogeneic hematopoietic (allo-HSCT) bayan maganin autologous CD7 CAR-T don maganin cutar sankarar lymphoblastic mai saurin kamuwa da cutar T-cell mai saurin kamuwa da cutar sankarar lymphoblastic/lymphoblastic lymphoma (R/R T-ALL/T-LBL).
Labarin Marasa Lafiya | Ciwon Leukemia Mai Tsanani (AML-M2) Wanda Ya Rasu: Shekaru 9 Bayan Dashen, Ya Rungumi Ikon Bege da Sake Haihuwa
Labari mai ratsa zuciya daga Asibitin Lu Daopei, wanda ke nuna tafiyar wani namiji mai shekaru 32 da ya tsira daga cutar AML-M2, wanda bayan an yi masa dashen ƙwayoyin halitta na haploid, ya yi bikin cika shekaru 9 da samun sauƙi, yana rayuwa cike da rayuwa mai cike da kuzari, wanda ƙauna, bege, da juriya suka ƙarfafa.
Ingantaccen Yawan Rayuwa Tare da Tsarin Bu/Cy+Melphalan da Bu/Cy+Thiotepa a cikin Dashen Kwayoyin Haploidentical don Ciwon Mara Mai Sauƙi na Megakaryoblastic Leukemia (AMKL)
Wani bincike da Dr. Zhi-Jie Wei da tawagarsa suka gabatar a ASH 2024 ya nuna ingancin tsarin da aka gyara na Bu/Cy a cikin dashen ƙwayoyin halittar jini na haploidical hematopoietic don cutar sankarar jini mai saurin kamuwa da cutar Megakaryoblastic (AMKL), wanda ke nuna sakamako mai kyau na rayuwa ga marasa lafiya da ke fama da cikakkiyar gafara (CR).
Sakamako Mai Kyau ga Maganin CD7 CAR-T a Maganin Cutar Lymphoma ta T-Cell da ta Daɗe/Tana Ragewa a ASH 2024
A taron shekara-shekara na ASH na shekarar 2024, Farfesa Lu Peihua daga Asibitin Lu Daopei ya gabatar da sakamako mai ban mamaki daga gwajin Phase I na maganin ƙwayoyin CAR-T na CD7 don cutar lymphoma na T-cell da ke dawowa/mai jurewa (R/R PTCL), wanda ke nuna inganci mai kyau da aminci mai kyau.
Cin Nasara a Cikin Maganin CAR-T Don Ciwon Daji na T-Cell
Duk da cewa maganin CAR-T ya kawo sauyi a tsarin maganin cutar kansar B-cell, akwai manyan ƙalubale wajen magance cutar kansar T-cell. Wani bita na baya-bayan nan ya binciki sarkakiyar maganin CAR-T a cikin cutar kansar jini ta T-cell da kuma hanyoyin magance waɗannan cikas.
Ci gaba a Maganin Farko ga Manya B-ALL: Cikakken Bayani daga The Lancet Hematology
Wani bita na baya-bayan nan a cikin Nazarin Haihuwar Lancet yana nuna ci gaba mai mahimmanci a cikin maganin farko na sabbin ƙwayoyin B-cell na manya da aka gano suna da cutar sankarar lymphoblastic mai tsanani (B-ALL), yana mai da hankali kan hanyoyin magani na musamman, sabbin hanyoyin rigakafi, da ingantattun sakamakon marasa lafiya.
Matashi Ya Dawo Da Fata Bayan Ganewar AML M4a Tafiya Ta Juriya Da Warkewa
Bayan fama da cutar sankarar myeloid leukemia (AML-M4a) da kuma yin dashen ƙwayoyin halitta masu ceton rai, wani matashin majiyyaci ya sami bege, lafiya, da kuma sabon farawa, godiya ga kulawar da Asibitin Lu Daopei ya bayar.
Sabbin Ci gaba a Tsarin Jijiyoyi na Farko da Ganewa (PCNSL)
Ci gaban da aka samu kwanan nan a binciken cutar da kuma maganin cutar Lymphoma ta tsarin jijiyoyi na farko (PCNSL) ya ba wa marasa lafiya sabuwar fata. Wani bita da aka yi kwanan nan daga Jami'ar Stanford ya nuna muhimmancin gano cutar da wuri da kuma sabbin hanyoyin magani, ciki har da maganin chemotherapy da kuma hanyoyin magance cutar da aka yi niyya.
Labarin Marasa Lafiya: Cin Nasara Kan Ciwon Sanyi Mai Tsanani na Myeloid da Sake Haihuwa Bayan Dashen Kwayoyin Halitta
Wani majiyyaci namiji mai shekaru 34 ya bayyana tafiyarsa mai ban sha'awa ta yaƙi da cutar sankarar myeloid mai tsanani (AML), yana shan maganin chemotherapy sau da yawa da kuma dashen ƙwayoyin halitta, da kuma murnar shekaru uku na murmurewa da sabon bege.